NCT05914480

Brief Summary

Identify prevalence of sepsis in ICU of Assiut university hospital 2.Clarify different causes of sepsis in patients admitted to ICU . 3.Compare causes and outcomes of sepsis between diabetics versus non diabetics . 4.Screening for the co1.mmonest organism causing sepsis in critically ill patients .

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
85

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 13, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 22, 2023

Completed
9 days until next milestone

Study Start

First participant enrolled

July 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

June 26, 2023

Status Verified

June 1, 2023

Enrollment Period

1 year

First QC Date

June 13, 2023

Last Update Submit

June 22, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Detect the most common organism causing sepsis in ICU

    Applying culture and sensitivity test for patients developed sepsis on admission and follow up will direct us for appropriate treatment for all patients

    20 days

Secondary Outcomes (1)

  • Incidence of sepsis in diabetics versus non diabetics in ICU.

    15 days

Interventions

Investigations to detect cause of sepsis as blood cultures ,urine cultures and from catheters .also PCR for legionella will be done

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients admitted to ICU diagnosed as sepsis or septic shock even on admission or later on then subdivided into 2 groups 1\_Hyperglycemic (diabetic and non diabetic) .2\_Normoglycemic(diabetic and non diabetic)

You may not qualify if:

  • previous history of pulmonary problem Previous history of cardiac disease Previous history of autoimmune disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Sepsis

Interventions

Polymerase Chain Reaction

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nucleic Acid Amplification TechniquesGenetic TechniquesInvestigative Techniques

Central Study Contacts

Mai Ahmed fathi, Specialist

CONTACT

Hala khalafalla el sherif, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Specialist

Study Record Dates

First Submitted

June 13, 2023

First Posted

June 22, 2023

Study Start

July 1, 2023

Primary Completion

July 1, 2024

Study Completion

August 1, 2024

Last Updated

June 26, 2023

Record last verified: 2023-06